Old Web
English
Sign In
Acemap
>
authorDetail
>
Jo Canham
Jo Canham
Cardiff University
Capecitabine
Pathology
Oxaliplatin
Medicine
Internal medicine
3
Papers
27
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Induction oxaliplatin capecitabine followed by switch to carboplatin-paclitaxel based RT versus continuing oxaliplatin capecitabine RT in operable esophageal adenocarcinoma: Survival analysis of the randomized phase II neoscope trial.
2020
Journal of Clinical Oncology
Somnath Mukherjee
Chris Nicholas Hurt
Catrin Cox
Ganesh Radhakrishna
Sarah Gwynne
Andrew Bateman
Simon Gollins
Maria A. Hawkins
Jo Canham
Heike I. Grabsch
Stephen Falk
Ricky A. Sharma
Ruby Ray
Rajarshi Roy
Wendy Wade
R. Maggs
David Sebag-Montefiore
Tim Maughan
Gareth Griffiths
Tom Crosby
Show All
Source
Cite
Save
Citations (1)
NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
2017
European Journal of Cancer
Somnath Mukherjee
Chris Nicholas Hurt
S. Gwynne
David Sebag-Montefiore
G. Radhakrishna
Simon Gollins
M. Hawkins
Heike I. Grabsch
Gareth Owen Jones
Stephen Falk
Ricky A. Sharma
Andrew Bateman
Rajarshi Roy
Ruby Ray
Jo Canham
Gareth Griffiths
Tim Maughan
T. Crosby
Show All
Source
Cite
Save
Citations (23)
NEOSCOPE: A randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine (OXCAP) or carboplatin/paclitaxel (CarPac) based chemoradiation (CRT) as pre-operative regimen for resectable oesophageal adenocarcinoma.
2016
Journal of Clinical Oncology
Somnath Mukherjee
Chris Nicholas Hurt
S. Gwynne
Andrew Bateman
Simon Gollins
G. Radhakrishna
Jo Canham
Ruby Ray
Heike I. Grabsch
Ricky A. Sharma
R. Maggs
M. Hawkins
David Sebag-Montefiore
Tim Maughan
Gareth Griffiths
Tom Crosby
Show All
Source
Cite
Save
Citations (3)
1